Astaxanthin-Mediated Bacterial Lethality: Evidence from Oxidative Stress Contribution and Molecular Dynamics Simulation

• Published in: Oxidative medicine and cellular longevity 2021, Vol.2021 (1), p.7159652-7159652
• Main Authors: Aribisala, Jamiu Olaseni, Nkosi, Sonto, Idowu, Kehinde, Nurain, Ismaila Olanrewaju, Makolomakwa, Gaositwe Melvin, Shode, Francis O., Sabiu, Saheed
• Format: Article
• Language: English
• Subjects: Anti-Bacterial Agents - chemistry; Anti-Bacterial Agents - pharmacology; Antibiotics; Bacteria; Bacteria - drug effects; Bacteria - growth & development; Bacterial infections; Binding sites; Infections; Ligands; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Organisms; Oxidative Stress; Proteins; Simulation; Software; Xanthophylls - chemistry; Xanthophylls - pharmacology
• ISSN: 1942-0900; 1942-0994
• DOI: 10.1155/2021/7159652

The involvement of cellular oxidative stress in antibacterial therapy has remained a topical issue over the years. In this study, the contribution of oxidative stress to astaxanthin-mediated bacterial lethality was evaluated in silico and in vitro. For the in vitro analysis, the minimum inhibitory concentration (MIC) of astaxanthin was lower than that of novobiocin against Staphylococcus aureus but generally higher than those of the reference antibiotics against other test organisms. The level of superoxide anion of the tested organisms increased significantly following treatment with astaxanthin when compared with DMSO-treated cells. This increase compared favorably with those observed with the reference antibiotics and was consistent with a decrease in the concentration of glutathione (GSH) and corresponding significant increase in ADP/ATP ratio. These observations are suggestive of probable involvement of oxidative stress in antibacterial capability of astaxanthin and in agreement with the results of the in silico evaluations, where the free energy scores of astaxanthins’ complexes with topoisomerase IV ParC and ParE were higher than those of the reference antibiotics. These observations were consistent with the structural stability and compactness of the complexes as astaxanthin was observed to be more stable against topoisomerase IV ParC and ParE than DNA Gyrase A and B. Put together, findings from this study underscored the nature and mechanism of antibacterial action of astaxanthin that could suggest practical approaches in enhancing our current knowledge of antibacterial arsenal and aid in the novel development of alternative natural topo2A inhibitor.